Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil

Ferrucci, 1990, Iron oxide-enhanced MR imaging of the liver and spleen: Review of the first 5 years, AJR, 155, 943, 10.2214/ajr.155.5.2120963

Runge, 1994, Contrast-enhanced MR imaging of the liver, JMRI, 4, 281, 10.1002/jmri.1880040311

Hahn, 1991, Gastrointestinal contrast agents, AJR, 156, 252, 10.2214/ajr.156.2.1898795

McLachlan, 1994, Phase I clinical evaluation of a new iron oxide MR contrast agent, J. Magn. Reson. Imaging, 4, 301, 10.1002/jmri.1880040313

Weissleder, 1994, MR lymphography: Study of a high-efficiency lymphotrophic agent, Radiology, 191, 225, 10.1148/radiology.191.1.8134576

Jung, 1995, Surface properties of superparamagnetic iron oxide MR contrast agents, Magn. Reson. Imaging, 13, 675, 10.1016/0730-725X(95)00023-A

Groman, 1989

Palmacci, 1993

Whitehead, 1987

Sullivan, 1984, Iron in drugs, spectrophotometric method, final action, 676

Sullivan, 1976, Iron in drugs, spectrophotometric method, final action, JAOAC, 59, 1156

Powder Diffraction File. Joint Committee on Powder Diffraction Standards (JCPDS). File No. 19–629; 24–81; 25–1402.

Murad, 1984, Iron oxides and oxyhydroxides

Bettaut, 1962, Particle sizes and their statistics from Debye-Scherrer lines, Vol 3, 318

Guinier, 1963

O'Grady, 1983, Particle size analysis in ferrofluids, J. Magnetism Magn. Mater., 39, 91, 10.1016/0304-8853(83)90407-9

Matyi, 1987, Particle size, particle size distribution, and related measurements of supported metal catalysts, Catal. Rev. Sci. Eng., 29, 41, 10.1080/01614948708067547

Morawetz, 1965

Weiner, 1984, Particle sizing using photon correlation spectroscopy, 109

Daniels, 1969, Mössbauer spectroscopy of stoichiometric and nonstoichiometric magnetite, J. Phys. Chem. Solids., 30, 1561, 10.1016/0022-3697(69)90217-0

Morris, 1985, Spectral and other physicochemical properties of submicron powders of hematite (α-Fe2O3), maghemite (γ-Fe2O3), magnetite (Fe3O4), goethite (α-FeOOH), and lepidocrocite (γ-FeOOH), J. Geophys. Res., 90, 3126, 10.1029/JB090iB04p03126

Greenwood, 1971

Thomas, 1986, Mössbauer spectroscopy of magnetic solids, 191

Moerup, 1980, Magnetic microcrystals. Applic, Mössbauer Spectrosc., 2, 1

Murad, 1982, The characterization of goethite by Mössbauer spectroscopy, Am. Mineral., 67, 1007

Eckert, 1984, Mössbauer spectroscopy of mixed valence compounds

Moerup, 1976, Modified theory for Mössbauer spectra of superparamagnetic particles: Application to iron oxide (Fe3O4), J. de Physique, Coll. C6, 287

McNab, 1968, Magnetic properties of magnetite (Fe3O4) microcrystals, J. Appl. Phys., 39, 5703, 10.1063/1.1656035

Shen, 1993, Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties, MRM, 29, 599, 10.1002/mrm.1910290504

Sjogren, 1994, Magnetic characterization of iron oxides for magnetic resonance imaging, Magn. Reson. Med., 31, 268, 10.1002/mrm.1910310305

Bengele, 1994, Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration, Magn. Reson. Imaging, 12, 433, 10.1016/0730-725X(94)92537-2

Kawamura, 1990, Use of magnetite particles as a contrast agent for MR imaging of the liver, Radiology, 174, 357, 10.1148/radiology.174.2.2296645

Magin, 1991, Dextran magnetite as a liver contrast agent, Magn. Reson. Med., 20, 1, 10.1002/mrm.1910200102

Iannone, 1991, Blood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method, Magn. Reson. Med., 22, 435, 10.1002/mrm.1910220251

Fahlvik, 1990, Magnetic starch microspheres efficacy and elimination a new organ-specific contrast agent for magnetic resonance imaging, Invest. Radiol., 25, 113, 10.1097/00004424-199002000-00003

Fahlvik, 1990, Magnetic starch microspheres biodistribution and biotransformation a new organ-specific contrast agent for magnetic resonance imaging, Invest. Radiol., 25, 793, 10.1097/00004424-199007000-00008

Lonnemark, 1988, Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract, Acta Radiol., 29, 599, 10.3109/02841858809171945

Rinck, 1991, Oral magnetic particles in MR imaging of the abdomen and pelvis, Radiology, 178, 775, 10.1148/radiology.178.3.1994417

Lauffer, 1985, Iron-ethylenebis-2-hydroxyphenylglycine as an hepatobiliary magnetic resonance contrast agent. Initial imaging and biodistribution studies, J. Comput. Assist. Tomogr., 9, 431, 10.1097/00004728-198505000-00001

1989, E-130

Weinmann, 1984, Characteristics of gadolinium di ethylenetriamine penta acetic-acid complex: A potential NMR contrast agent, AJR, 142, 619, 10.2214/ajr.142.3.619